SlideShare una empresa de Scribd logo
1 de 55
:Prepared by
       .Dr.Mohamed Shekhani
.References: Davidson PP of Medicine
:Introduction
• Poisoning is a major cause of death in young adults& 10% of
  hospital admissions.
• Most deaths occur before patients reach medical attention&
  mortality is much <1% in those admitted to hospital.
Introduction: In developed countries
• The most frequent cause is intentional drug overdose in the context
  of self-harm& usually involves prescribed or ‘over-the-counter’
  OTC medicines.
• Accidental poisoning is also common, esp in children& elderly.
• Household /agricultural products such as pesticides/ herbicides are
  common sources of poisoning &associated with a much higher case
  fatality.
• Toxicity also may occur as a result of alcohol or recreational
  substance use, or following occupational or enviro exposure.
General approach:Triage/resuscitation:
• Those seriously poisoned must be identified early so that
  appropriate management is not delayed.
• Vital signs:
• Identifying the poison(s) by obtaining adequate information.
• Prevent reattempt by identifying those at risk.
• Those with external contamination with chemical or environmental
  toxins should undergo appropriate decontamination.
• Critically ill patients must be resuscitated(abc).
• (GCS) is commonly employed to assess conscious level or AVPU
  (alert/verbal/painful/unresponsive).
General approach:Triage/resuscitation:
General approach: Triage/resuscitation:
• An (ECG) should be performed & cardiac monitoring instituted in
  all patients with CV features or where exposure to potentially
  cardiotoxic substances is suspected.
• Those who need antidotes given according to weight.
• Benzodiazepine/flumazenil
• Opiods/Nalorphine.
• Paracetamol/N-Acetyl cysteine.
• Substances that are unlikely to be toxic in humans should be
  identified so that inappropriate admission & intervention are
  avoided
General approach: Triage/resuscitation:
General approach: Triage/resuscitation:
:Clinical assessment
• History &examination .
• Patients may be unaware or confused about what they have
  taken, or may exaggerate (or less commonly underestimate) the
  size of the overdose, &rarely mislead medical staff deliberately.
• Toxic causes of abnormal physical signs SHOULBE BE KNOWN.
• Cluster of clinical features (‘toxidrome’) suggestive of poisoning
  with a particular drug type IDENTIFIED.
• Poisoning is a common cause of coma, especially in younger people,
  but it is important to exclude other potential causes, unless the
  aetiology is certain.
• Anticholinergic
  – Hot As Hades
  – Blind As A Bat
  – Dry As A Bone
  – Red As A Beet
  – Mad As A Hatter
:Investigations
• Urea, electrolytes, creatinine should be measured in most patients.
• Arterial blood gases should be checked in those with significant
  respiratory or circulatory compromise, or when poisoning with
  substances likely to affect acid–base status is suspected.
• Calculation of anion and osmolar gaps may help to inform diagnosis
  for a limited number of specific substances.
• Management may be facilitated by measurement of the amount of
  toxin in the blood.
• Qualitative urine screens or potential toxins including near-
  patient testing kits have a limited clinical role.
• Occasionally, for medicoegal reasons, it is useful to save blood
  and urine for subsequent measurement of drug concentrations.
psychiatric assessment
• All patients presenting with deliberate drug overdose should
  undergo psychosocial evaluation by a health professional with
  appropriate training prior to discharge ,once the patient has
  recovered from any features of poisoning, unless there is an urgent
  issue such as uncertainty about his or her capacity to decline
  medical treatment.
General management
• Patients presenting with eye or skin contamination should
  undergo appropriate local decontamination procedures.
Gastrointestinal decontamination
• Patients who have ingested potentially life- threatening
  quantities of toxins may be considered for GIT decontamination if
  poisoning has been recent.
• Induction of emesis using ipecacuanha is now never recommended.
Activated charcoal
• Given orally as slurry, activated charcoal absorbs toxins in the
  bowel as a result of its large surface area.
• If given sufficiently early, it can prevent absorption of an
  important proportion of the ingested dose of toxin.
• The efficacy decreases with time.
• Current guidelines do not advocate use >1 hour after overdose in
  most circumstances,EXCEPT when delayed-release preparation has
   been taken or when gastric emptying may be delayed.
Activated charcoal
• Some toxins do not bind to activated charcoal so it will not affect
  their absorption.
• In patients with an impaired swallow or a reduced level of
  consciousness, the use of activated charcoal, even via a nasogastric
  tube, carries a risk of aspiration pneumonitis.
• This risk can be reduced but not completely removed by
  protecting the airway with a cuffed endotracheal tube.
• Multiple doses of oral activated charcoal (50 g every 4 hours) may
  enhance the elimination of some drugs at any time after
  poisoning and are recommended for serious poisoning with some
  substances .
Activated charcoal
• They achieve their effect by interrupting enterohepatic circulation
  or by reducing the concentration of free drug in the gut lumen, to
  the extent that drug diffuses from the blood back into the bowel to
  be absorbed on to the charcoal: so-called ‘GIT dialysis’. A laxa-
  tive is generally given with the charcoal to reduce the risk of
  constipation or intestinal obstruction by charcoal ‘briquette’
  formation in the gut lumen.
• Recent evidence suggests that single or multiple doses of
  activated charcoal do not improve clinical outcomes after poisoning
  with pesticides or oleander.
SUBSTANCES NOT BOUND BY
            CHARCOAL
• Alcohols And        • Heavy Metals
  Glycols               – Iron
• Corrosives            – Lead
  – Alkalis             – Lithium
  – Acids               – Mercury
• Cyanide             • Hydrocarbons
• Saline Cathartics
Gastric aspiration & lavage
• Gastric aspiration and/or lavage is now very infrequently
  indicated in acute poisoning, as it is no more effective than
  activated charcoal, and complications are common, especially
  aspiration.
• Use may be justified for life-threatening overdoses of some
  substances that are not absorbed by activated charcoal
Whole bowel irrigation
• This is occasionally indicated to enhance the elimination of ingested
  packets or slow-release tablets that are not absorbed by activated
  charcoal (e.g. iron, lithium), but use is controversial.
• It is performed by administration of large quantities of
  polyethylene glycol and electrolyte solution (1–2 L/hr for an adult),
  often via a nasogastric tube, until the rectal effluent is clear.
• Contraindications include inadequate airway protection,
  haemodynamic instability, gastrointestinal haemorrhage,
  obstruction or ileus.
• Whole bowel irrigation does not cause osmotic changes but may
  precipitate nausea and vomiting, abdominal pain and electrolyte
  disturbances
Urinary alkalinisation
• Urinary excretion of weak acids& bases is affected by urinary pH,
  which changes the extent to which they are ionised.
• Highly ionised molecules pass poorly through lipid membranes and
  therefore little tubular reabsorption occurs and urinary excretion
  is increased.
• If the urine is alkalinised (pH > 7.5) by the administration of
  sodium bicarbonate (e.g. 1.5 L of 1.26% sodium bicar-bonate over 2
  hrs), weak acids (e.g. salicylates, methotrexate , herbicides 2,4-
  dichlorophenoxyacetic acid and mecoprop) are highly ionised and
  so their uri-nary excretion is enhanced.
• This technique should be distinguished from forced alkaline
  diuresis, in which large volumes of fluid with diuretic are given in
  addi-tion to alkalinisation(no longer used because of the risk of
  fluid overload).
Urinary alkalinisation
• Urinary alkalinisation is currently recommended for patients
  with clinically significant salicylate poi-soning when the criteria
  for haemodialysis are not met
• It is also sometimes used for poisoning with methotrexate.
• Complications include alkalaemia, hypokalaemia, occasionally
  alkalotic tetany.
• Hypocalcaemia is rare.
Haemodialysis & haemoperfusion
• These can enhance the elimination of poisons that have a small
  volume of distribution & a long half-life after overdose, useful when
  the episode of poisoning is sufficiently severe to justify invasive
  elimination methods.
• The toxin must be small enough to cross the dialysis membrane
  (haemodialysis) or must bind to activated charcoal
  (haemoperfusion) .
• Haemodialysis may also correct acid–base and metabolic
  disturbances associated with poisoning
Antidotes
• Are available for some poisons
• Work by a variety of mechanisms: for example:
• Specific antagonism (e.g. isoproterenol for β–blockers) or
  Pharmacological antagonism( flumazenil for benzodiazepines &
  nalorphine for opoids)
• Chelation (e.g. desferrioxamine for iron)
• Reduction (e.g. methylene blue for dapsone).
Supportive care
• For most poisons, antidotes & methods to accelerate elimination
  are inappropriate, unavailable or incompletely effective.
• Outcome is dependent on appropriate nursing & supportive care,
  & on treatment of complications.
• Patients should be monitored carefully until the effects of any
  toxins have dissipated.
:Study SCQs
•   1. In Poisoning all are true except::
•   A. The most common cause of death in young adults.
•   B. The most common cause of hospital admissions.
•   C. Most die before reaching hospital.
•   D. In-Hospital Mortality should be less than 1%.
•   E.The most common cause of death in elderly persons.
:Study SCQs
•   2.The most way of poisoning is:
•   A.Accidental.
•   B.Intentional.
•   C. Agricultural products intake.
•   D. Alcolol.
•   E. Opoid intake.
:Study SCQs
•   3.Common drugs involved in poisoning include all except:
•   A.NSAIDs.
•   B.Acetaminophen.
•   C. Antidepresants.
•   D.Lead.
•   E.Alcohol.
:Study SCQs
• 4. Poisons with serious effects requiring urgent actions
  include all except:
• A.Acetaminophen.
• B.Ethylene glycol.
• C.Oral contraceptives.
• E. CO.
:Study SCQs
• 5.Poisoning is recognized by the following toxidromes
  except:
• A.Anticholinergic.
• B. Adrenergic.
• C.Cholinergic.
• D.Stimulants.
• E.Opoid.
:Study SCQs
• 6.Regarding poisoning in elderly,all are true except:
• A. Commonly caused by intentional poisoning.
• B. Mortality in higher.
• C. Psychiatric disease as a cause is less than in the young.
• D. Higher risk of recurrent attempts if due to chronic
  illnesses.
• E. Toxic prescriptions are common.
:Study SCQs
• 7. Drug level as part of management of poisoning is
  indicated in all except:
• A.Acetaminophen.
• B. Oral hypoglycemic.
• C.CO.
• D.Iron.
• E.Digoxin.
:Study SCQs
• 9.All these poisons cause acidosis with normal lactate
  except:
• A.Aspirin.
• B.Methanol.
• C. Ethelene glycol.
• D.Paraldehyde.
• E.Iron.
:Study SCQs
• 10.The following are not adsorbed by activated charcoal
  except:
• A.Cyanide.
• B.Glycols.
• C.Aspirin.
• D.Lead.
• E.Lithium.
:Study SCQs
• 11.The best management of drug-poisoned patient
  presenting within 1 hour is:
• A.Whole bowel irrigation.
• B.Tincher ipecan vomint induction.
• C.Activated charcoal.
• D.Hemodialysis.
• E.Hemofiltration.
:Study SCQs
• 12.The antidote that acts by direct pharmacological
  antagonism is:
• A.Deferoxamine for iron.
• B.Nalorphine for opoids.
• C.Alkaline diuresis for salycylates.
• D.Praladoxime for organophosphorous poisoning.
• E.Methylene blue for Dapson.
:Study SCQs
• 13.The most urgent treatment of organophosphorous
  poisonig is:
• A.Atropin injection.
• B.Praladoxime.
• C.Mechanical ventilation.
• D.O2.
• E.Bronchial lavage.

Más contenido relacionado

La actualidad más candente

Drug treatment of iron deficiency anaemia
Drug treatment of iron deficiency anaemiaDrug treatment of iron deficiency anaemia
Drug treatment of iron deficiency anaemia
Naser Tadvi
 

La actualidad más candente (20)

Heavy metal poisoning
Heavy metal poisoningHeavy metal poisoning
Heavy metal poisoning
 
Corrosive poisoning by Dr.Ashwin Menon
Corrosive poisoning by Dr.Ashwin MenonCorrosive poisoning by Dr.Ashwin Menon
Corrosive poisoning by Dr.Ashwin Menon
 
Acetaminophen
AcetaminophenAcetaminophen
Acetaminophen
 
General Principles of Management of Poisoning
General Principles of Management of PoisoningGeneral Principles of Management of Poisoning
General Principles of Management of Poisoning
 
Drugs used in musculoskeletal disorders i
Drugs used in musculoskeletal disorders iDrugs used in musculoskeletal disorders i
Drugs used in musculoskeletal disorders i
 
Anesthetics - Pharmacology
Anesthetics - PharmacologyAnesthetics - Pharmacology
Anesthetics - Pharmacology
 
Household poisons
Household poisonsHousehold poisons
Household poisons
 
Toxidromes
ToxidromesToxidromes
Toxidromes
 
Cannabis poisoning
Cannabis poisoningCannabis poisoning
Cannabis poisoning
 
Emesis & anti emetics medications
Emesis & anti emetics medications Emesis & anti emetics medications
Emesis & anti emetics medications
 
Anticholinergic drugs by. shuaib
Anticholinergic drugs by. shuaibAnticholinergic drugs by. shuaib
Anticholinergic drugs by. shuaib
 
Poisoning
PoisoningPoisoning
Poisoning
 
Antidote
AntidoteAntidote
Antidote
 
Antidotes
AntidotesAntidotes
Antidotes
 
Antidote
AntidoteAntidote
Antidote
 
Antipyretic drugs
Antipyretic drugsAntipyretic drugs
Antipyretic drugs
 
Antihistamine presentation
Antihistamine presentation Antihistamine presentation
Antihistamine presentation
 
Toxicology
ToxicologyToxicology
Toxicology
 
Drug treatment of iron deficiency anaemia
Drug treatment of iron deficiency anaemiaDrug treatment of iron deficiency anaemia
Drug treatment of iron deficiency anaemia
 
Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.Poisoning plus MCQs 2012.
Poisoning plus MCQs 2012.
 

Destacado

medicine.Cns infections 2.(dr.muhamad tahir)
medicine.Cns infections 2.(dr.muhamad tahir)medicine.Cns infections 2.(dr.muhamad tahir)
medicine.Cns infections 2.(dr.muhamad tahir)
student
 
phychiatry.Suicide.(dr.rebwar)
phychiatry.Suicide.(dr.rebwar)phychiatry.Suicide.(dr.rebwar)
phychiatry.Suicide.(dr.rebwar)
student
 
Anesthesia Lecture 2
Anesthesia Lecture 2Anesthesia Lecture 2
Anesthesia Lecture 2
student
 
gynaecology.PCOS.(dr.hana)
gynaecology.PCOS.(dr.hana)gynaecology.PCOS.(dr.hana)
gynaecology.PCOS.(dr.hana)
student
 
medicine.myeloma.(dr.anwar shexa)
medicine.myeloma.(dr.anwar shexa)medicine.myeloma.(dr.anwar shexa)
medicine.myeloma.(dr.anwar shexa)
student
 
E.N.T.Pharyngitis.(dr.muaid)
E.N.T.Pharyngitis.(dr.muaid)E.N.T.Pharyngitis.(dr.muaid)
E.N.T.Pharyngitis.(dr.muaid)
student
 
medicine.CRF2.(dr.kawa)
medicine.CRF2.(dr.kawa)medicine.CRF2.(dr.kawa)
medicine.CRF2.(dr.kawa)
student
 
Medicine.Multiple myeloma.(dr.sabir)
Medicine.Multiple myeloma.(dr.sabir)Medicine.Multiple myeloma.(dr.sabir)
Medicine.Multiple myeloma.(dr.sabir)
student
 
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
student
 
medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)
student
 
anaesthesia.Monitoring 2(dr.amr)
anaesthesia.Monitoring 2(dr.amr)anaesthesia.Monitoring 2(dr.amr)
anaesthesia.Monitoring 2(dr.amr)
student
 
ophthalmology.squint.(dr.khald)
ophthalmology.squint.(dr.khald)ophthalmology.squint.(dr.khald)
ophthalmology.squint.(dr.khald)
student
 
dermatology.Connective tissue diseases.(dr.darseem)
dermatology.Connective tissue diseases.(dr.darseem)dermatology.Connective tissue diseases.(dr.darseem)
dermatology.Connective tissue diseases.(dr.darseem)
student
 
psychiatry.Somatoform disorders animation part i.(dr.nzar)
psychiatry.Somatoform disorders animation part i.(dr.nzar)psychiatry.Somatoform disorders animation part i.(dr.nzar)
psychiatry.Somatoform disorders animation part i.(dr.nzar)
student
 
radiology.CVS 2 .(dr.abeer)
radiology.CVS 2 .(dr.abeer)radiology.CVS 2 .(dr.abeer)
radiology.CVS 2 .(dr.abeer)
student
 
pediatrics.Kawasaki disease.(dr.khalid)
pediatrics.Kawasaki disease.(dr.khalid)pediatrics.Kawasaki disease.(dr.khalid)
pediatrics.Kawasaki disease.(dr.khalid)
student
 
neurosurgery.Hydrocephalus.(dr.ali omer)
neurosurgery.Hydrocephalus.(dr.ali omer)neurosurgery.Hydrocephalus.(dr.ali omer)
neurosurgery.Hydrocephalus.(dr.ali omer)
student
 
gynaecology.Benign tumor of the uterus.(dr.sundus)
gynaecology.Benign tumor of the uterus.(dr.sundus)gynaecology.Benign tumor of the uterus.(dr.sundus)
gynaecology.Benign tumor of the uterus.(dr.sundus)
student
 
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
student
 

Destacado (19)

medicine.Cns infections 2.(dr.muhamad tahir)
medicine.Cns infections 2.(dr.muhamad tahir)medicine.Cns infections 2.(dr.muhamad tahir)
medicine.Cns infections 2.(dr.muhamad tahir)
 
phychiatry.Suicide.(dr.rebwar)
phychiatry.Suicide.(dr.rebwar)phychiatry.Suicide.(dr.rebwar)
phychiatry.Suicide.(dr.rebwar)
 
Anesthesia Lecture 2
Anesthesia Lecture 2Anesthesia Lecture 2
Anesthesia Lecture 2
 
gynaecology.PCOS.(dr.hana)
gynaecology.PCOS.(dr.hana)gynaecology.PCOS.(dr.hana)
gynaecology.PCOS.(dr.hana)
 
medicine.myeloma.(dr.anwar shexa)
medicine.myeloma.(dr.anwar shexa)medicine.myeloma.(dr.anwar shexa)
medicine.myeloma.(dr.anwar shexa)
 
E.N.T.Pharyngitis.(dr.muaid)
E.N.T.Pharyngitis.(dr.muaid)E.N.T.Pharyngitis.(dr.muaid)
E.N.T.Pharyngitis.(dr.muaid)
 
medicine.CRF2.(dr.kawa)
medicine.CRF2.(dr.kawa)medicine.CRF2.(dr.kawa)
medicine.CRF2.(dr.kawa)
 
Medicine.Multiple myeloma.(dr.sabir)
Medicine.Multiple myeloma.(dr.sabir)Medicine.Multiple myeloma.(dr.sabir)
Medicine.Multiple myeloma.(dr.sabir)
 
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
E.N.T.Anatomy of pharynx & neck spaces(dr.muaid)
 
medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)
 
anaesthesia.Monitoring 2(dr.amr)
anaesthesia.Monitoring 2(dr.amr)anaesthesia.Monitoring 2(dr.amr)
anaesthesia.Monitoring 2(dr.amr)
 
ophthalmology.squint.(dr.khald)
ophthalmology.squint.(dr.khald)ophthalmology.squint.(dr.khald)
ophthalmology.squint.(dr.khald)
 
dermatology.Connective tissue diseases.(dr.darseem)
dermatology.Connective tissue diseases.(dr.darseem)dermatology.Connective tissue diseases.(dr.darseem)
dermatology.Connective tissue diseases.(dr.darseem)
 
psychiatry.Somatoform disorders animation part i.(dr.nzar)
psychiatry.Somatoform disorders animation part i.(dr.nzar)psychiatry.Somatoform disorders animation part i.(dr.nzar)
psychiatry.Somatoform disorders animation part i.(dr.nzar)
 
radiology.CVS 2 .(dr.abeer)
radiology.CVS 2 .(dr.abeer)radiology.CVS 2 .(dr.abeer)
radiology.CVS 2 .(dr.abeer)
 
pediatrics.Kawasaki disease.(dr.khalid)
pediatrics.Kawasaki disease.(dr.khalid)pediatrics.Kawasaki disease.(dr.khalid)
pediatrics.Kawasaki disease.(dr.khalid)
 
neurosurgery.Hydrocephalus.(dr.ali omer)
neurosurgery.Hydrocephalus.(dr.ali omer)neurosurgery.Hydrocephalus.(dr.ali omer)
neurosurgery.Hydrocephalus.(dr.ali omer)
 
gynaecology.Benign tumor of the uterus.(dr.sundus)
gynaecology.Benign tumor of the uterus.(dr.sundus)gynaecology.Benign tumor of the uterus.(dr.sundus)
gynaecology.Benign tumor of the uterus.(dr.sundus)
 
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
dermatology. disorders of sebaceous and sweat glands.(dr.faraydwn)
 

Similar a medicine.Poisoningintroduction.(dr.muhamad shaikhane)

medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
medicine.Poisoningbyspecificdrugs.(dr.shaikhani)medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
student
 
Approach to a case of poisoning arif
Approach to a case of poisoning arifApproach to a case of poisoning arif
Approach to a case of poisoning arif
Arif Khan
 

Similar a medicine.Poisoningintroduction.(dr.muhamad shaikhane) (20)

Poisoning introduction plus MCQs2012.
Poisoning introduction  plus MCQs2012.Poisoning introduction  plus MCQs2012.
Poisoning introduction plus MCQs2012.
 
Poisoning
PoisoningPoisoning
Poisoning
 
Therapy and management of toxicosis
Therapy and management of toxicosis Therapy and management of toxicosis
Therapy and management of toxicosis
 
Treating poison and overdose overview
Treating poison and overdose  overviewTreating poison and overdose  overview
Treating poison and overdose overview
 
POISONING.pptx
POISONING.pptxPOISONING.pptx
POISONING.pptx
 
Drug overdose in general
Drug overdose in generalDrug overdose in general
Drug overdose in general
 
POISONING - PDF.pdf
POISONING - PDF.pdfPOISONING - PDF.pdf
POISONING - PDF.pdf
 
medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
medicine.Poisoningbyspecificdrugs.(dr.shaikhani)medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
medicine.Poisoningbyspecificdrugs.(dr.shaikhani)
 
Poisoning by specific drugs.
Poisoning by specific drugs.Poisoning by specific drugs.
Poisoning by specific drugs.
 
Gut decontamination or methods of poison removal in clinical toxicology
Gut decontamination or methods of poison removal in clinical toxicology Gut decontamination or methods of poison removal in clinical toxicology
Gut decontamination or methods of poison removal in clinical toxicology
 
ALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASEALCOHOLIC LIVER DISEASE
ALCOHOLIC LIVER DISEASE
 
Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
 
Pediatrics drug poisoning
Pediatrics drug poisoning Pediatrics drug poisoning
Pediatrics drug poisoning
 
Toxico overdose-lec07-1223099219105884-9
Toxico overdose-lec07-1223099219105884-9Toxico overdose-lec07-1223099219105884-9
Toxico overdose-lec07-1223099219105884-9
 
Poisoning in Pediatrics
Poisoning in PediatricsPoisoning in Pediatrics
Poisoning in Pediatrics
 
Approach to a case of poisoning arif
Approach to a case of poisoning arifApproach to a case of poisoning arif
Approach to a case of poisoning arif
 
Gout (drug and treatment )
Gout (drug and treatment )Gout (drug and treatment )
Gout (drug and treatment )
 
Paraquat toxicity explained.pptx
Paraquat toxicity explained.pptxParaquat toxicity explained.pptx
Paraquat toxicity explained.pptx
 
Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
 
Clinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoningClinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoning
 

Más de student

Development
DevelopmentDevelopment
Development
student
 
Electrocardiographymain
ElectrocardiographymainElectrocardiographymain
Electrocardiographymain
student
 
Immunization2
Immunization2Immunization2
Immunization2
student
 
Gyne,obst slides
Gyne,obst slidesGyne,obst slides
Gyne,obst slides
student
 
Catch up vaccine
Catch up vaccineCatch up vaccine
Catch up vaccine
student
 
Assessment examination1
Assessment examination1Assessment examination1
Assessment examination1
student
 
Assessment examination
Assessment examinationAssessment examination
Assessment examination
student
 
Medications
MedicationsMedications
Medications
student
 
Hysterosalpingography
HysterosalpingographyHysterosalpingography
Hysterosalpingography
student
 
بسم الله الرحمن الرحيمAph
بسم الله الرحمن الرحيمAphبسم الله الرحمن الرحيمAph
بسم الله الرحمن الرحيمAph
student
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
student
 
Gestational trophoblastic disease 2
Gestational trophoblastic disease 2Gestational trophoblastic disease 2
Gestational trophoblastic disease 2
student
 
Disfunctional uterine bleeding.gynaecology
Disfunctional uterine bleeding.gynaecologyDisfunctional uterine bleeding.gynaecology
Disfunctional uterine bleeding.gynaecology
student
 
anaestheisa
anaestheisaanaestheisa
anaestheisa
student
 
meidicine. first seizure.(dr.muhamad tahir)
meidicine. first seizure.(dr.muhamad tahir)meidicine. first seizure.(dr.muhamad tahir)
meidicine. first seizure.(dr.muhamad tahir)
student
 
medicine.Coma managment.(dr.muhamad tahir)
medicine.Coma managment.(dr.muhamad tahir)medicine.Coma managment.(dr.muhamad tahir)
medicine.Coma managment.(dr.muhamad tahir)
student
 
medicine.Age and aging lecture 1.(dr.aso)
medicine.Age and aging lecture 1.(dr.aso)medicine.Age and aging lecture 1.(dr.aso)
medicine.Age and aging lecture 1.(dr.aso)
student
 
medicine.Vasculitis 2.(dr.kawa)
medicine.Vasculitis 2.(dr.kawa)medicine.Vasculitis 2.(dr.kawa)
medicine.Vasculitis 2.(dr.kawa)
student
 
surgery.Congenital heart disease.(dr.aram)
surgery.Congenital heart disease.(dr.aram)surgery.Congenital heart disease.(dr.aram)
surgery.Congenital heart disease.(dr.aram)
student
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)
student
 

Más de student (20)

Development
DevelopmentDevelopment
Development
 
Electrocardiographymain
ElectrocardiographymainElectrocardiographymain
Electrocardiographymain
 
Immunization2
Immunization2Immunization2
Immunization2
 
Gyne,obst slides
Gyne,obst slidesGyne,obst slides
Gyne,obst slides
 
Catch up vaccine
Catch up vaccineCatch up vaccine
Catch up vaccine
 
Assessment examination1
Assessment examination1Assessment examination1
Assessment examination1
 
Assessment examination
Assessment examinationAssessment examination
Assessment examination
 
Medications
MedicationsMedications
Medications
 
Hysterosalpingography
HysterosalpingographyHysterosalpingography
Hysterosalpingography
 
بسم الله الرحمن الرحيمAph
بسم الله الرحمن الرحيمAphبسم الله الرحمن الرحيمAph
بسم الله الرحمن الرحيمAph
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
 
Gestational trophoblastic disease 2
Gestational trophoblastic disease 2Gestational trophoblastic disease 2
Gestational trophoblastic disease 2
 
Disfunctional uterine bleeding.gynaecology
Disfunctional uterine bleeding.gynaecologyDisfunctional uterine bleeding.gynaecology
Disfunctional uterine bleeding.gynaecology
 
anaestheisa
anaestheisaanaestheisa
anaestheisa
 
meidicine. first seizure.(dr.muhamad tahir)
meidicine. first seizure.(dr.muhamad tahir)meidicine. first seizure.(dr.muhamad tahir)
meidicine. first seizure.(dr.muhamad tahir)
 
medicine.Coma managment.(dr.muhamad tahir)
medicine.Coma managment.(dr.muhamad tahir)medicine.Coma managment.(dr.muhamad tahir)
medicine.Coma managment.(dr.muhamad tahir)
 
medicine.Age and aging lecture 1.(dr.aso)
medicine.Age and aging lecture 1.(dr.aso)medicine.Age and aging lecture 1.(dr.aso)
medicine.Age and aging lecture 1.(dr.aso)
 
medicine.Vasculitis 2.(dr.kawa)
medicine.Vasculitis 2.(dr.kawa)medicine.Vasculitis 2.(dr.kawa)
medicine.Vasculitis 2.(dr.kawa)
 
surgery.Congenital heart disease.(dr.aram)
surgery.Congenital heart disease.(dr.aram)surgery.Congenital heart disease.(dr.aram)
surgery.Congenital heart disease.(dr.aram)
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)
 

Último

Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
laloo_007
 

Último (20)

Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
New 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck TemplateNew 2024 Cannabis Edibles Investor Pitch Deck Template
New 2024 Cannabis Edibles Investor Pitch Deck Template
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
 
Falcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business PotentialFalcon Invoice Discounting: Unlock Your Business Potential
Falcon Invoice Discounting: Unlock Your Business Potential
 

medicine.Poisoningintroduction.(dr.muhamad shaikhane)

  • 1. :Prepared by .Dr.Mohamed Shekhani .References: Davidson PP of Medicine
  • 2. :Introduction • Poisoning is a major cause of death in young adults& 10% of hospital admissions. • Most deaths occur before patients reach medical attention& mortality is much <1% in those admitted to hospital.
  • 3. Introduction: In developed countries • The most frequent cause is intentional drug overdose in the context of self-harm& usually involves prescribed or ‘over-the-counter’ OTC medicines. • Accidental poisoning is also common, esp in children& elderly. • Household /agricultural products such as pesticides/ herbicides are common sources of poisoning &associated with a much higher case fatality. • Toxicity also may occur as a result of alcohol or recreational substance use, or following occupational or enviro exposure.
  • 4. General approach:Triage/resuscitation: • Those seriously poisoned must be identified early so that appropriate management is not delayed. • Vital signs: • Identifying the poison(s) by obtaining adequate information. • Prevent reattempt by identifying those at risk. • Those with external contamination with chemical or environmental toxins should undergo appropriate decontamination. • Critically ill patients must be resuscitated(abc). • (GCS) is commonly employed to assess conscious level or AVPU (alert/verbal/painful/unresponsive).
  • 6. General approach: Triage/resuscitation: • An (ECG) should be performed & cardiac monitoring instituted in all patients with CV features or where exposure to potentially cardiotoxic substances is suspected. • Those who need antidotes given according to weight. • Benzodiazepine/flumazenil • Opiods/Nalorphine. • Paracetamol/N-Acetyl cysteine. • Substances that are unlikely to be toxic in humans should be identified so that inappropriate admission & intervention are avoided
  • 8.
  • 9.
  • 10.
  • 12. :Clinical assessment • History &examination . • Patients may be unaware or confused about what they have taken, or may exaggerate (or less commonly underestimate) the size of the overdose, &rarely mislead medical staff deliberately. • Toxic causes of abnormal physical signs SHOULBE BE KNOWN. • Cluster of clinical features (‘toxidrome’) suggestive of poisoning with a particular drug type IDENTIFIED. • Poisoning is a common cause of coma, especially in younger people, but it is important to exclude other potential causes, unless the aetiology is certain.
  • 13.
  • 14.
  • 15.
  • 16. • Anticholinergic – Hot As Hades – Blind As A Bat – Dry As A Bone – Red As A Beet – Mad As A Hatter
  • 17.
  • 18.
  • 19.
  • 20. :Investigations • Urea, electrolytes, creatinine should be measured in most patients. • Arterial blood gases should be checked in those with significant respiratory or circulatory compromise, or when poisoning with substances likely to affect acid–base status is suspected. • Calculation of anion and osmolar gaps may help to inform diagnosis for a limited number of specific substances. • Management may be facilitated by measurement of the amount of toxin in the blood. • Qualitative urine screens or potential toxins including near- patient testing kits have a limited clinical role. • Occasionally, for medicoegal reasons, it is useful to save blood and urine for subsequent measurement of drug concentrations.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. psychiatric assessment • All patients presenting with deliberate drug overdose should undergo psychosocial evaluation by a health professional with appropriate training prior to discharge ,once the patient has recovered from any features of poisoning, unless there is an urgent issue such as uncertainty about his or her capacity to decline medical treatment.
  • 26. General management • Patients presenting with eye or skin contamination should undergo appropriate local decontamination procedures.
  • 27. Gastrointestinal decontamination • Patients who have ingested potentially life- threatening quantities of toxins may be considered for GIT decontamination if poisoning has been recent. • Induction of emesis using ipecacuanha is now never recommended.
  • 28. Activated charcoal • Given orally as slurry, activated charcoal absorbs toxins in the bowel as a result of its large surface area. • If given sufficiently early, it can prevent absorption of an important proportion of the ingested dose of toxin. • The efficacy decreases with time. • Current guidelines do not advocate use >1 hour after overdose in most circumstances,EXCEPT when delayed-release preparation has been taken or when gastric emptying may be delayed.
  • 29. Activated charcoal • Some toxins do not bind to activated charcoal so it will not affect their absorption. • In patients with an impaired swallow or a reduced level of consciousness, the use of activated charcoal, even via a nasogastric tube, carries a risk of aspiration pneumonitis. • This risk can be reduced but not completely removed by protecting the airway with a cuffed endotracheal tube. • Multiple doses of oral activated charcoal (50 g every 4 hours) may enhance the elimination of some drugs at any time after poisoning and are recommended for serious poisoning with some substances .
  • 30. Activated charcoal • They achieve their effect by interrupting enterohepatic circulation or by reducing the concentration of free drug in the gut lumen, to the extent that drug diffuses from the blood back into the bowel to be absorbed on to the charcoal: so-called ‘GIT dialysis’. A laxa- tive is generally given with the charcoal to reduce the risk of constipation or intestinal obstruction by charcoal ‘briquette’ formation in the gut lumen. • Recent evidence suggests that single or multiple doses of activated charcoal do not improve clinical outcomes after poisoning with pesticides or oleander.
  • 31.
  • 32.
  • 33. SUBSTANCES NOT BOUND BY CHARCOAL • Alcohols And • Heavy Metals Glycols – Iron • Corrosives – Lead – Alkalis – Lithium – Acids – Mercury • Cyanide • Hydrocarbons • Saline Cathartics
  • 34. Gastric aspiration & lavage • Gastric aspiration and/or lavage is now very infrequently indicated in acute poisoning, as it is no more effective than activated charcoal, and complications are common, especially aspiration. • Use may be justified for life-threatening overdoses of some substances that are not absorbed by activated charcoal
  • 35. Whole bowel irrigation • This is occasionally indicated to enhance the elimination of ingested packets or slow-release tablets that are not absorbed by activated charcoal (e.g. iron, lithium), but use is controversial. • It is performed by administration of large quantities of polyethylene glycol and electrolyte solution (1–2 L/hr for an adult), often via a nasogastric tube, until the rectal effluent is clear. • Contraindications include inadequate airway protection, haemodynamic instability, gastrointestinal haemorrhage, obstruction or ileus. • Whole bowel irrigation does not cause osmotic changes but may precipitate nausea and vomiting, abdominal pain and electrolyte disturbances
  • 36. Urinary alkalinisation • Urinary excretion of weak acids& bases is affected by urinary pH, which changes the extent to which they are ionised. • Highly ionised molecules pass poorly through lipid membranes and therefore little tubular reabsorption occurs and urinary excretion is increased. • If the urine is alkalinised (pH > 7.5) by the administration of sodium bicarbonate (e.g. 1.5 L of 1.26% sodium bicar-bonate over 2 hrs), weak acids (e.g. salicylates, methotrexate , herbicides 2,4- dichlorophenoxyacetic acid and mecoprop) are highly ionised and so their uri-nary excretion is enhanced. • This technique should be distinguished from forced alkaline diuresis, in which large volumes of fluid with diuretic are given in addi-tion to alkalinisation(no longer used because of the risk of fluid overload).
  • 37. Urinary alkalinisation • Urinary alkalinisation is currently recommended for patients with clinically significant salicylate poi-soning when the criteria for haemodialysis are not met • It is also sometimes used for poisoning with methotrexate. • Complications include alkalaemia, hypokalaemia, occasionally alkalotic tetany. • Hypocalcaemia is rare.
  • 38. Haemodialysis & haemoperfusion • These can enhance the elimination of poisons that have a small volume of distribution & a long half-life after overdose, useful when the episode of poisoning is sufficiently severe to justify invasive elimination methods. • The toxin must be small enough to cross the dialysis membrane (haemodialysis) or must bind to activated charcoal (haemoperfusion) . • Haemodialysis may also correct acid–base and metabolic disturbances associated with poisoning
  • 39.
  • 40. Antidotes • Are available for some poisons • Work by a variety of mechanisms: for example: • Specific antagonism (e.g. isoproterenol for β–blockers) or Pharmacological antagonism( flumazenil for benzodiazepines & nalorphine for opoids) • Chelation (e.g. desferrioxamine for iron) • Reduction (e.g. methylene blue for dapsone).
  • 41. Supportive care • For most poisons, antidotes & methods to accelerate elimination are inappropriate, unavailable or incompletely effective. • Outcome is dependent on appropriate nursing & supportive care, & on treatment of complications. • Patients should be monitored carefully until the effects of any toxins have dissipated.
  • 42.
  • 43.
  • 44. :Study SCQs • 1. In Poisoning all are true except:: • A. The most common cause of death in young adults. • B. The most common cause of hospital admissions. • C. Most die before reaching hospital. • D. In-Hospital Mortality should be less than 1%. • E.The most common cause of death in elderly persons.
  • 45. :Study SCQs • 2.The most way of poisoning is: • A.Accidental. • B.Intentional. • C. Agricultural products intake. • D. Alcolol. • E. Opoid intake.
  • 46. :Study SCQs • 3.Common drugs involved in poisoning include all except: • A.NSAIDs. • B.Acetaminophen. • C. Antidepresants. • D.Lead. • E.Alcohol.
  • 47. :Study SCQs • 4. Poisons with serious effects requiring urgent actions include all except: • A.Acetaminophen. • B.Ethylene glycol. • C.Oral contraceptives. • E. CO.
  • 48. :Study SCQs • 5.Poisoning is recognized by the following toxidromes except: • A.Anticholinergic. • B. Adrenergic. • C.Cholinergic. • D.Stimulants. • E.Opoid.
  • 49. :Study SCQs • 6.Regarding poisoning in elderly,all are true except: • A. Commonly caused by intentional poisoning. • B. Mortality in higher. • C. Psychiatric disease as a cause is less than in the young. • D. Higher risk of recurrent attempts if due to chronic illnesses. • E. Toxic prescriptions are common.
  • 50. :Study SCQs • 7. Drug level as part of management of poisoning is indicated in all except: • A.Acetaminophen. • B. Oral hypoglycemic. • C.CO. • D.Iron. • E.Digoxin.
  • 51. :Study SCQs • 9.All these poisons cause acidosis with normal lactate except: • A.Aspirin. • B.Methanol. • C. Ethelene glycol. • D.Paraldehyde. • E.Iron.
  • 52. :Study SCQs • 10.The following are not adsorbed by activated charcoal except: • A.Cyanide. • B.Glycols. • C.Aspirin. • D.Lead. • E.Lithium.
  • 53. :Study SCQs • 11.The best management of drug-poisoned patient presenting within 1 hour is: • A.Whole bowel irrigation. • B.Tincher ipecan vomint induction. • C.Activated charcoal. • D.Hemodialysis. • E.Hemofiltration.
  • 54. :Study SCQs • 12.The antidote that acts by direct pharmacological antagonism is: • A.Deferoxamine for iron. • B.Nalorphine for opoids. • C.Alkaline diuresis for salycylates. • D.Praladoxime for organophosphorous poisoning. • E.Methylene blue for Dapson.
  • 55. :Study SCQs • 13.The most urgent treatment of organophosphorous poisonig is: • A.Atropin injection. • B.Praladoxime. • C.Mechanical ventilation. • D.O2. • E.Bronchial lavage.